TipRanks
Advertisement
Advertisement
Aeon Biopharma designates Paul Lee as acting chief regulatory officer
PremiumThe FlyAeon Biopharma designates Paul Lee as acting chief regulatory officer
1M ago
Aeon Biopharma price target lowered to $1.20 from $5 at H.C. Wainwright
Premium
The Fly
Aeon Biopharma price target lowered to $1.20 from $5 at H.C. Wainwright
2M ago
AEON Biopharma Reports Q2 Results, Advances ABP-450 Program
Premium
Company Announcements
AEON Biopharma Reports Q2 Results, Advances ABP-450 Program
2M ago
AEON Biopharma boosts liquidity with additional share sale
PremiumCompany AnnouncementsAEON Biopharma boosts liquidity with additional share sale
2M ago
Aeon announces pricing of upsized $13.75M public offering
Premium
The Fly
Aeon announces pricing of upsized $13.75M public offering
3M ago
AEON Biopharma shareholders approve directors and auditor slate
Premium
Company Announcements
AEON Biopharma shareholders approve directors and auditor slate
4M ago
Is AEON a Buy, Before Earnings?
PremiumPre-EarningsIs AEON a Buy, Before Earnings?
6M ago
Aeon Biopharma announces FDA feedback after Type 2a meeting
Premium
The Fly
Aeon Biopharma announces FDA feedback after Type 2a meeting
6M ago
Aeon Biopharma appoints John Bencich as CFO
Premium
The Fly
Aeon Biopharma appoints John Bencich as CFO
7M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―